Literature DB >> 16054836

G-protein-coupled receptor signaling and the EGF network in endocrine systems.

Minnie Hsieh1, Marco Conti.   

Abstract

The epidermal growth factor (EGF) network is composed of a complex array of growth factors synthesized as precursors and expressed on the cell surface. These latent growth factors are activated by cleavage and shedding from the cell surface and act by binding to various homo- and hetero-dimers of the EGF receptors (ErbBs). Although the exact molecular steps are poorly understood, ligand binding to G-protein-coupled receptors as diverse as the beta-adrenoceptors or the lysophosphatidic acid receptors leads to shedding of EGF growth factors and activation of EGF receptors. Recent observations from the pituitary and in the ovary are providing new insight into the role of this network in endocrine systems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054836     DOI: 10.1016/j.tem.2005.07.005

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  24 in total

1.  A delayed gonadotropin-dependent and growth factor-mediated activation of the extracellular signal-regulated kinase 1/2 cascade negatively regulates aromatase expression in granulosa cells.

Authors:  Nebojsa Andric; Mario Ascoli
Journal:  Mol Endocrinol       Date:  2006-09-14

Review 2.  Paracrinicity: the story of 30 years of cellular pituitary crosstalk.

Authors:  C Denef
Journal:  J Neuroendocrinol       Date:  2008-01       Impact factor: 3.627

3.  CCAAT/enhancer-binding proteins (C/EBP)-α and -β are essential for ovulation, luteinization, and the expression of key target genes.

Authors:  Heng-Yu Fan; Zhilin Liu; Peter F Johnson; JoAnne S Richards
Journal:  Mol Endocrinol       Date:  2010-12-22

4.  Targeted disruption of Mapk14 (p38MAPKalpha) in granulosa cells and cumulus cells causes cell-specific changes in gene expression profiles that rescue COC expansion and maintain fertility.

Authors:  Zhilin Liu; Heng-Yu Fan; Yibin Wang; Joanne S Richards
Journal:  Mol Endocrinol       Date:  2010-07-07

Review 5.  Activated epidermal growth factor receptor in ovarian cancer.

Authors:  Laurie G Hudson; Reema Zeineldin; Melina Silberberg; M Sharon Stack
Journal:  Cancer Treat Res       Date:  2009

6.  Proteomic analysis of the balance between survival and cell death responses in cisplatin-mediated ototoxicity.

Authors:  Samson Jamesdaniel; Dalian Ding; Mohammad Habiby Kermany; Bruce A Davidson; Paul R Knight; Richard Salvi; Donald E Coling
Journal:  J Proteome Res       Date:  2008-06-26       Impact factor: 4.466

7.  A co-culture system reveals the involvement of intercellular pathways as mediators of the lutropin receptor (LHR)-stimulated ERK1/2 phosphorylation in Leydig cells.

Authors:  Koji Shiraishi; Mario Ascoli
Journal:  Exp Cell Res       Date:  2007-07-17       Impact factor: 3.905

Review 8.  EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.

Authors:  Laurie G Hudson; Natalie M Moss; M Sharon Stack
Journal:  Future Oncol       Date:  2009-04       Impact factor: 3.404

9.  P2Y2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and ErbB3 in human salivary gland cells.

Authors:  Ann M Ratchford; Olga J Baker; Jean M Camden; Shivaji Rikka; Michael J Petris; Cheikh I Seye; Laurie Erb; Gary A Weisman
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

10.  Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells.

Authors:  Lidia Albanito; Diego Sisci; Saveria Aquila; Elvira Brunelli; Adele Vivacqua; Antonio Madeo; Rosamaria Lappano; Deo Prakash Pandey; Didier Picard; Loredana Mauro; Sebastiano Andò; Marcello Maggiolini
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.